Literature DB >> 2334159

Acute, rapidly progressive renal failure with simultaneous use of amphotericin B and pentamidine.

D Antoniskis1, R A Larsen.   

Abstract

We report four cases of acute reversible renal failure in patients with acquired immune deficiency syndrome who received both amphotericin B (for systemic mycoses) and pentamidine isethionate (for Pneumocystis carinii pneumonia). The concurrent use of amphotericin B with either inhaled pentamidine or trimethoprim-sulfamethoxazole did not cause significant renal impairment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334159      PMCID: PMC171617          DOI: 10.1128/AAC.34.3.470

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS.

Authors:  W T BUTLER; J E BENNETT; D W ALLING; P T WERTLAKE; J P UTZ; G J HILL
Journal:  Ann Intern Med       Date:  1964-08       Impact factor: 25.391

2.  Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia.

Authors:  K A Western; D R Perera; M G Schultz
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

3.  Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.

Authors:  F R Sattler; R Cowan; D M Nielsen; J Ruskin
Journal:  Ann Intern Med       Date:  1988-08-15       Impact factor: 25.391

4.  Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.

Authors:  J M Wharton; D L Coleman; C B Wofsy; J M Luce; W Blumenfeld; W K Hadley; L Ingram-Drake; P A Volberding; P C Hopewell
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

5.  Pentamidine pharmacokinetics in patients with AIDS with impaired renal function.

Authors:  J E Conte; R A Upton; E T Lin
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

Review 6.  Pentamidine: a review.

Authors:  M Sands; M A Kron; R B Brown
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

Review 7.  Nephrotoxic acute renal failure due to common drugs.

Authors:  G A Porter; W M Bennett
Journal:  Am J Physiol       Date:  1981-07

8.  Recurrent reversible acute renal failure from amphotericin.

Authors:  P Sacks; S K Fellner
Journal:  Arch Intern Med       Date:  1987-03
  8 in total
  7 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.

Authors:  R Heylen; R Miller
Journal:  Genitourin Med       Date:  1996-08

3.  Acute kidney injury in an infant with severe combined immunodeficiency: Answers.

Authors:  Georgia Malakasioti; Nele Alders; Giovanna Lucchini; Iek L Cheng; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2019-07-16       Impact factor: 3.714

Review 4.  Important drug interactions in dermatology.

Authors:  T C Roos; H F Merk
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 5.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

6.  In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors:  Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Nebulized pentamidine-induced acute renal allograft dysfunction.

Authors:  Siddhesh Prabhavalkar; Agnes Masengu; Declan O'Rourke; Joanne Shields; Aisling Courtney
Journal:  Case Rep Transplant       Date:  2013-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.